Mechanistic Fingerprinting Reveals Kinetic Signatures of Resistance to Daptomycin and Host Defense Peptides in <i>Streptococcus mitis-oralis</i>.
Yeaman. Michael R MR; Chan. Liana C LC; Mishra. Nagendra N NN; Bayer. Arnold S AS
Key Findings
- A daptomycin‑resistant S. mitis-oralis strain (351-D10) shows a subpopulation that hyper‑accumulates daptomycin compared to the susceptible strain.
- Both daptomycin‑susceptible and -resistant strains experience similar membrane hyper‑polarization and killing kinetics when exposed to LL‑37.
- No significant differences were observed in membrane permeabilization, lipid turnover, or regulated cell death between the strains after LL‑37 exposure.
Practical Outcomes
- For biohackers considering LL‑37 as an antimicrobial boost, this work suggests that resistance to daptomycin does not necessarily reduce LL‑37’s activity, but LL‑37 also does not overcome the resistance mechanisms that protect the bacteria. It highlights that LL‑37 may have limited added benefit against daptomycin‑resistant strains of S. mitis-oralis, so relying on it for broad antimicrobial protection should be done cautiously.
Summary
The study looked at how a common mouth bacteria (Streptococcus mitis-oralis) becomes resistant to the antibiotic daptomycin and whether that resistance also makes it less vulnerable to the human immune peptide LL‑37. While the resistant strain still binds daptomycin, it shows a small group of cells that take up a lot more of the drug. Both the normal and resistant bacteria react similarly to LL‑37, meaning the resistance to daptomycin doesn’t automatically make the bacteria tougher for LL‑37 to kill.
Abstract
<i>Streptococcus mitis-oralis (S. mitis-oralis)</i> infections are increasingly prevalent in specific populations, including neutropenic cancer and endocarditis patients. <i>S. mitis-oralis</i> strains have a propensity to evolve rapid, high-level and durable resistance to daptomycin (DAP-R) in vitro and in vivo, although the mechanism(s) involved remain incompletely defined. We examined mechanisms of DAP-R versus cross-resistance to cationic host defense peptides (HDPs), using an isogenic <i>S. mitis-oralis</i> strain-pair: (i) DAP-susceptible (DAP-S) parental 351-WT (DAP MIC = 0.5 µg/mL), and its (ii) DAP-R variant 351-D10 (DAP MIC > 256 µg/mL). DAP binding was quantified by flow cytometry, in-parallel with temporal (1-4 h) killing by either DAP or comparative prototypic cationic HDPs (hNP-1; LL-37). Multicolor flow cytometry was used to determine kinetic cell responses associated with resistance or susceptibility to these molecules. While overall DAP binding was similar between strains, a significant subpopulation of 351-D10 cells hyper-accumulated DAP (>2-4-fold vs. 351-WT). Further, both DAP and hNP-1 induced cell membrane (CM) hyper-polarization in 351-WT, corresponding to significantly greater temporal DAP-killing (vs. 351-D10). No strain-specific differences in CM permeabilization, lipid turnover or regulated cell death were observed post-exposure to DAP, hNP-1 or LL-37. Thus, the adaptive energetics of the CM appear coupled to the outcomes of interactions of S. <i>mitis-oralis</i> with DAP and selected HDPs. In contrast, altered CM permeabilization, proposed as a major mechanism of action of both DAP and HDPs, did not differentiate DAP-S vs. DAP-R phenotypes in this <i>S. mitis-oralis</i> strain-pair.
Study Information
pubmed
2021
2021-04-08T00:00:00.000Z
10.3390/antibiotics10040404
2
39